How Sleep Shapes Cancer Risk and Treatment Outcomes
Sleep might just be your most powerful untapped ally against cancer.
👋 Welcome to this edition of Sleepletter™ where we offer you easy-to-read insights from the latest research papers from the field of sleep neurobiology and clinical sleep medicine. Sign up to also receive Sleepletter by email.
🏆 Want to optimize your sleep or attend my "Ask Me Anything" session? Join us for exclusive seminars and events that unveil the science of sleep and receive personalized, actionable and science-backed recommendations how to improve sleep. Subscribe here!
🎧 NEW! Sleepletter is now on Spotify—not just an audio version of the newsletter, but a deeper, more dynamic dive into each topic, exploring the science of sleep in a way that informs and surprises.
We often find ourselves sacrificing sleep, whether for work, stress, or daily demands, even though most of us understand its importance. But what we may not fully realize is just how powerful sleep is as a biological force. Far from being a passive state, sleep is now recognized as an active defense system, one that may play a surprisingly critical role in reducing the risk of cancer and even improving outcomes after diagnosis.
Let’s start with the basics. Cancer isn’t a single disease, but nearly all types share one thing in common: they involve cells growing out of control. To stop this, the body relies on a wide array of defense mechanisms—DNA repair systems, immune surveillance, hormonal regulation, and apoptosis (programmed cell death). Sleep affects nearly all of them.
Take the immune system as an example. Natural killer (NK) cells are frontline defenders that patrol the body for abnormal or cancerous cells. Just one night of partial sleep deprivation can reduce NK cell activity by around 70% in healthy adults. That’s a significant decline in of one of the body’s most powerful anticancer defenses. The connection gets more alarming with chronic sleep disruption. A 2025 review summarize decades of studies showing that both short and long sleep durations have been associated with higher risks for breast, lung, colorectal, and prostate cancers—though these relationships may be tissue-specific and complex. Notably, sleeping less than 6 hours a night was linked to a 16% increased risk of lung cancer in one meta-analysis.
But it’s not just how long you sleep. Sleep quality and disruption matter too. Insomnia—defined by difficulty falling or staying asleep—is common in cancer patients, but may also precede a diagnosis. In a study of over 33,000 women, those reporting insomnia had a 2.4-times greater risk of developing breast cancer. A meta-analysis of over 570,000 individuals found that insomnia was associated with a 24% increased risk of cancer overall, with the strongest link to thyroid cancer. Other studies have linked insomnia with thyroid, oral, and prostate cancers as well. Obstructive sleep apnea (OSA)—a condition marked by intermittent pauses in breathing during sleep—has also been tied to cancer. People with OSA have higher risks of melanoma, kidney, and liver cancers, as well as breast cancer by 36%. The mechanism? Potentially chronic intermittent hypoxia (low blood oxygen levels) which is a hallmark of apnea, which activates pro-growth factors like HIF-1α and may promote tumor aggressiveness and metastasis.
What about cancer risk after diagnosis in people who sleep poorly? Over two-thirds of people with cancer report sleep problems, from insomnia to excessive sleepiness. These issues don’t just affect comfort—they may impact treatment outcomes. In breast and ovarian cancer, poor sleep has been associated with shorter survival and faster disease progression. In one cohort, fragmented sleep alone predicted worse survival outcomes.
Why would this happen? One likely pathway is inflammation. Poor sleep raises inflammatory cytokines (e.g. IL-6, TNF-α), which are already elevated in many cancers. This inflammatory burden can impair healing, worsen fatigue, and promote tumor growth. Sleep disruption also dysregulates cortisol and catecholamines, weakening immune surveillance and fueling angiogenesis—the growth of new blood vessels that feed tumors.
Even sleep stage disruption matters. Cancer patients often show reduced deep (N3) and REM sleep, especially during chemotherapy. These stages are critical for memory, emotional regulation, and immune balance—and their loss may compound cancer-related symptoms like cognitive fog and mood instability.
There’s another twist: some sleep disorders may reduce cancer defense. For example, in narcolepsy, the brain loses orexin-producing neurons. But orexin also regulates apoptosis in some tumor types. Experimental studies show that orexin A can shrink pancreatic and colorectal tumors in vitro—raising the intriguing possibility that orexin loss might remove a natural brake on tumor growth.
The silver lining? Sleep might not just reflect cancer risk—it could be a target for improving outcomes. In mice, fragmented sleep accelerates tumor growth, while restoring sleep slows it. In humans, treating OSA with CPAP reduces inflammatory markers and may reverse pro-cancer gene expression signatures. Cognitive-behavioral therapy for insomnia (CBT-I) improves not only sleep but quality of life and possibly even treatment tolerance in cancer patients.
The bottom line: sleep isn’t "just" about feeling rested tomorrow - it’s a form of biological defense. It regulates everything from immune surveillance to tumor microenvironments, hormone levels, and inflammation. In the context of cancer, sleep is not a side issue—it’s central. So the next time you think of sleep as optional, remember: it might just be your most powerful untapped ally against cancer.
***
About the author
Alen Juginović is a medical doctor and postdoctoral researcher in the Department of Neurobiology at Harvard Medical School studying the effect of poor sleep quality on health. He is the author of Sleep Science Made Simple, a book that explains how sleep affects the brain and body using clear, accessible language for both professionals and the general public. He is a member of the Editorial Board of the Journal of Clinical Sleep Medicine, the official journal of the American Academy of Sleep Medicine. As a keynote speaker at conferences and teacher at Harvard College, he often discusses sleep's importance during the educational process and in media appearances. Alen is also focused on personalized sleep optimization for individuals and athletes (e.g. jet lag management), as well as being an advisor/investor/consultant for companies and individuals in the sleep field. He leads a team at Med&X Association organizing international award-winning conferences, including the Plexus Conference, which drew over 2,400 participants from 30+ countries, featuring 10 Nobel laureates and medical leaders. Med&X also collaborates with research labs and clinics from leading universities and hospitals around the world offering invaluable internships to help accelerate the development of top medical students, physicians and scientists. Feel free to contact Alen via LinkedIn for any inquiries.
Disclaimer: The content provided in this newsletter is for informational and educational purposes only. It is not intended as medical or professional advice. The reader should consult with a medical professional for medical conditions or concerns, and with a financial or legal professional regarding any other specific needs or inquiries they may have related to the material discussed.
The writer expressly disclaims responsibility, obligation, or liability for actions taken by the reader in their unique circumstances based on any guidance, suggestions or recommendations made in this newsletter related to sleep health, optimization or hygiene. This content is not a substitute for personalized medical diagnosis, treatment or care from a trained physician.
The writer has made good faith efforts to confirm that all sleep science, research or health statistics referenced from third party sources are accurately represented. However, no warranty is made as to completeness or ongoing accuracy. Readers agree any reliance on newsletter content for decision making is at their sole discretion and risk. The writer is released of liability or claims related to applied use of this general educational content on sleep physiology or best practices.
Cartoon images generated with Adobe Firefly.